- Trials with a EudraCT protocol (114)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
114 result(s) found for: Cardiovascular Diseases AND Acute Myocardial Infarction AND Mortality.
Displaying page 1 of 6.
| EudraCT Number: 2020-004748-27 | Sponsor Protocol Number: EPIDAURUS-2020 | Start Date*: 2022-04-21 | |||||||||||
| Sponsor Name:LMU University Hospital Munich | |||||||||||||
| Full Title: Escalated single platelet inhibition for one month plus direct oral anticoagulation in patients with atrial fibrillation and acute coronary syndrome undergoing percutaneous coronary intervention | |||||||||||||
| Medical condition: Patients with atrial fibrillation and ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) (biomarker -positive acute coronary syndrome) und... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-003218-36 | Sponsor Protocol Number: 82646 | Start Date*: 2023-06-05 |
| Sponsor Name:Radboudumc | ||
| Full Title: The safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage | ||
| Medical condition: Acute myocardial infarction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-001437-27 | Sponsor Protocol Number: P150801 | Start Date*: 2016-12-30 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
| Full Title: Efficacy of furosemide versus vascular filling in Patients with Acute Myocardial Infarction with Right Ventricular Extension: a multicentric randomized controlled trial. | |||||||||||||
| Medical condition: Myocardial infarction with right ventricular extension. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-023394-19 | Sponsor Protocol Number: 9129 | Start Date*: 2012-11-13 | |||||||||||
| Sponsor Name:Maatschap Cardiologie Isala | |||||||||||||
| Full Title: Early Beta blocker Administration before reperfusion in patients with ST-Elevation Myocardial Infarction who are planned to undergo primary PCI | |||||||||||||
| Medical condition: Patients with acute ST elevation myocardial infarction, scheduled for emergency coronary angioplasty | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-002868-17 | Sponsor Protocol Number: 633765 | Start Date*: 2016-05-06 | |||||||||||
| Sponsor Name:Fundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC) | |||||||||||||
| Full Title: Secondary Prevention of Cardiovascular Disease in the Elderly | |||||||||||||
| Medical condition: Secondary Prevention of Major Cardiovascular Events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in post MI cohort. | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) ES (Ongoing) CZ (Completed) HU (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-005273-23 | Sponsor Protocol Number: 923 | Start Date*: 2012-01-30 | |||||||||||
| Sponsor Name:Liverpool Heart and Chest Hospital | |||||||||||||
| Full Title: HEAT-PPCI - How Effective are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention - A randomised controlled trial to compare unfractionated heparin versus bivalirudin in the trea... | |||||||||||||
| Medical condition: ST elevation myocardial infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-002699-42 | Sponsor Protocol Number: DANBLOCK | Start Date*: 2018-09-28 | |||||||||||
| Sponsor Name:Bispebjerg Frederiksberg Hospital | |||||||||||||
| Full Title: Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) | |||||||||||||
| Medical condition: Myocardial infarction. We wish to test whether long-term treatment with betablocker (bisoprolol, carvedilol, metoprolol or nebivolol) leads to better prognosis than no treatment in patients sufferi... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-002028-19 | Sponsor Protocol Number: RH-CARD-Pharma001 | Start Date*: 2022-02-01 | |||||||||||
| Sponsor Name:Department of Cardiology, Copenhagen University Hospital Rigshospitalet | |||||||||||||
| Full Title: Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development – a 2x2 multifactorial, double-blinded, randomized, ... | |||||||||||||
| Medical condition: Acute Myocardial Infarction with increased risk of Cardiogenic Shock. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-001495-11 | Sponsor Protocol Number: BAMI-01 | Start Date*: 2013-05-06 |
| Sponsor Name:Queen Mary University London | ||
| Full Title: The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BMMNC) on all causemortality in acute myocardial infarction | ||
| Medical condition: Myocardial Infarction with reduced Left Ventricular ejection fraction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) DK (Completed) GB (Completed) ES (Completed) IT (Completed) CZ (Completed) FI (Completed) NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-019844-38 | Sponsor Protocol Number: A6141116 | Start Date*: 2010-08-12 | |||||||||||
| Sponsor Name:Pfizer, S.A | |||||||||||||
| Full Title: A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of early the treatment with Eplerenone in patients with acute myocardial infarction. Estudio doble ciego, al... | |||||||||||||
| Medical condition: Infarto agudo de miocardio | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) SK (Completed) CZ (Completed) HU (Completed) GB (Completed) DE (Completed) NL (Completed) GR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-013713-99 | Sponsor Protocol Number: 2009.559 | Start Date*: 2010-04-14 | |||||||||||
| Sponsor Name:Hospices Civils de Lyon | |||||||||||||
| Full Title: Does Cyclosporine ImpRove Clinical oUtcome in ST elevation myocardial infarction patients (CIRCUS study) | |||||||||||||
| Medical condition: acute myocardial infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) BE (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-002161-19 | Sponsor Protocol Number: 13062017-23-1 | Start Date*: 2018-06-25 |
| Sponsor Name:Fakultní nemocnice Královské Vinohrady | ||
| Full Title: Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction | ||
| Medical condition: Cardiogenic shock in acute myocardial infarction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) SK (Completed) FR (Completed) PL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-001466-37 | Sponsor Protocol Number: A-STAMI | Start Date*: 2021-07-08 | ||||||||||||||||
| Sponsor Name:Västra Götalandsregionen, Sahlgrenska University Hospital | ||||||||||||||||||
| Full Title: Adenosine’s effect on STunning resolution in Acute Myocardial Infarction | ||||||||||||||||||
| Medical condition: Acute Myocardial Infarction | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: SE (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-001037-13 | Sponsor Protocol Number: 1245-0202 | Start Date*: 2021-05-20 | |||||||||||
| Sponsor Name:Boehringer Ingelheim International GmbH | |||||||||||||
| Full Title: A streamlined, multicentre, randomised, parallel group, double-blind placebo-controlled superiority trial to evaluate the effect of EMPAgliflozin on hospitalisation for heart failure and mortality ... | |||||||||||||
| Medical condition: Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) HU (Completed) PL (Completed) NL (Completed) BG (Completed) FR (Completed) DK (Completed) ES (Ongoing) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-002882-20 | Sponsor Protocol Number: 2013-03 | Start Date*: 2013-12-18 |
| Sponsor Name:Västra Götalands Center för utveckling av prehospital akutsjukvård | ||
| Full Title: DETermination of the role of OXygen in Acute Myocardial Infarction (DETO₂X-AMI) trial | ||
| Medical condition: Acute myocardial infarction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002485-40 | Sponsor Protocol Number: REBOOT-CNIC | Start Date*: 2018-03-22 |
| Sponsor Name:CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (CNIC) | ||
| Full Title: treatment with beta-blockers after myocardial infarction without reduced ejection fraction | ||
| Medical condition: STEMI or NSTEMI patients being discharged from the index hospitalization with a LVEF>40% without previous heart failure | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) IT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005172-28 | Sponsor Protocol Number: MHIPS-003 | Start Date*: 2016-03-29 |
| Sponsor Name:Montreal Heart Institute | ||
| Full Title: Colchicine Cardiovascular Outcomes Trial (COLCOT) | ||
| Medical condition: patients with atherosclerotic coronary artery disease (CAD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: PT (Completed) FR (Completed) ES (Completed) IT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000047-41 | Sponsor Protocol Number: FDY-5301-201 | Start Date*: 2017-07-06 | |||||||||||
| Sponsor Name:Faraday Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Phase 2A, Randomized, Double-Blind, Placebo- Controlled, Multi-Center Study of Intravenous FDY-5301 in Acute Myocardial Infarction | |||||||||||||
| Medical condition: Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) HU (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-001065-17 | Sponsor Protocol Number: EXO_01 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Fondazione IRCCS Policlinico San Matteo | ||
| Full Title: Early treatment with evOlocumab in patients with sT-elevation myocardial Infarction undergoing primary pCi | ||
| Medical condition: Acute myocardial infarction with persistent ST segment elevation (STEMI) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-005551-36 | Sponsor Protocol Number: NL79416.018.21 | Start Date*: 2022-08-05 |
| Sponsor Name: | ||
| Full Title: Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock from Acute Myocardial Infarction: A Multicenter Randomized... | ||
| Medical condition: Myocardial infarction related cardiogenic shock | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) DK (Trial now transitioned) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.